CCL2 and COVID-19: Megakaryocytes can also contribute to inflammatory signaling however no upregulation of inflammatory-related genes (e.g., CCL2, CLL3, IL-6 and CXCL8, etc.)were observed in the megakaryocytes from COVID-19 patients including those with encephalopathy (Supplementary Fig. 8d).